China is rushing a flurry of patient studies to identify the most effective life-saving treatments for people sickened by the novel coronavirus. Some 77 clinical t...

The UK Government has launched a public health campaign to provide clear advice to the public on how to slow the spread of Coronavirus and reduce the impact on NHS s...

With the death toll in China topping 425, the coronavirus, now officially classified as a global health threat by the World Health Organisation (WHO), is showing no ...

London has announced new partnerships with an ambition to become the first city in the world to stop new HIV infections and make preventable deaths from HIV a thing ...

The partners will deliver an integrated clinical research offer transforming Real World Data (RWD) from the global site and patient network on Clinerion’s Patient Ne...

New data has revealed that GlaxoSmithKline’s Bexsero (meningococcal group B vaccine) significantly reduces disease in infants. The vaccine was evaluated in two rea...

This years’s PM Society Awards, held on the 24th of January at Grosvenor House, saw Havas Lynx Group take home an impressive seven Gold awards across work for six di...

Enhertu (trastuzumab deruxtecan) has yielded high-level results from the positive registrational Phase II trial - DESTINY-Gastric01 - AstraZeneca and Daiichi Sankyo ...

A new study has revealed that Oncimmune’s EarlyCDT Lung test is more effective than the traditional computed tomography (CT) surveillance in lung cancer diagnosis. ...

Today, the U.S. Food and Drug Administration (FDA) approved Tepezza (teprotumumab-trbw) for the treatment of adults with thyroid eye disease, a rare condition where...